Nicoll, AJ; Panico, S; Freir, DB; Wright, D; Terry, C; Risse, E; Herron, CE; ... Collinge, J; + view all Nicoll, AJ; Panico, S; Freir, DB; Wright, D; Terry, C; Risse, E; Herron, CE; O'Malley, T; Wadsworth, JD; Farrow, MA; Walsh, DM; Saibil, HR; Collinge, J; - view fewer (2013) Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity. Nature Communications , 4 , Article 2416 . 10.1038/ncomms3416.

	PDF Nicoll_Nat_Comms_2013.pdf Download (2MB)
	PDF ncomms3416-s1.pdf Download (4MB)

Abstract

Growing evidence suggests water-soluble, non-fibrillar forms of amyloid-β protein (Aβ) have important roles in Alzheimer's disease with toxicities mimicked by synthetic Aβ1-42. However, no defined toxic structures acting via specific receptors have been identified and roles of proposed receptors, such as prion protein (PrP), remain controversial. Here we quantify binding to PrP of Aβ1-42 after different durations of aggregation. We show PrP-binding and PrP-dependent inhibition of long-term potentiation (LTP) correlate with the presence of protofibrils. Globular oligomers bind less avidly to PrP and do not inhibit LTP, whereas fibrils inhibit LTP in a PrP-independent manner. That only certain transient Aβ assemblies cause PrP-dependent toxicity explains conflicting reports regarding the involvement of PrP in Aβ-induced impairments. We show that these protofibrils contain a defined nanotubular structure with a previously unidentified triple helical conformation. Blocking the formation of Aβ nanotubes or their interaction with PrP might have a role in treatment of Alzheimer's disease.

Download activity - last month

Export as CSVJSONXML

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as JSONCSVXML

Archive Staff Only

View Item